S&P 500   3,332.94 (-1.19%)
DOW   28,948.93 (-0.93%)
QQQ   229.84 (-2.10%)
AAPL   312.22 (-2.52%)
FB   209.13 (-2.54%)
MSFT   177.87 (-3.55%)
GOOGL   1,485.10 (-2.10%)
AMZN   2,094.70 (-2.71%)
CGC   21.88 (-1.93%)
NVDA   292.62 (-5.21%)
BABA   212.34 (-2.61%)
MU   56.30 (-4.58%)
TSLA   888.25 (-1.24%)
AMD   53.13 (-7.23%)
T   38.39 (-0.60%)
ACB   1.65 (-1.79%)
F   7.91 (-1.50%)
NFLX   379.94 (-1.57%)
BAC   34.18 (-1.95%)
DIS   138.86 (-1.08%)
GILD   69.17 (+3.24%)
S&P 500   3,332.94 (-1.19%)
DOW   28,948.93 (-0.93%)
QQQ   229.84 (-2.10%)
AAPL   312.22 (-2.52%)
FB   209.13 (-2.54%)
MSFT   177.87 (-3.55%)
GOOGL   1,485.10 (-2.10%)
AMZN   2,094.70 (-2.71%)
CGC   21.88 (-1.93%)
NVDA   292.62 (-5.21%)
BABA   212.34 (-2.61%)
MU   56.30 (-4.58%)
TSLA   888.25 (-1.24%)
AMD   53.13 (-7.23%)
T   38.39 (-0.60%)
ACB   1.65 (-1.79%)
F   7.91 (-1.50%)
NFLX   379.94 (-1.57%)
BAC   34.18 (-1.95%)
DIS   138.86 (-1.08%)
GILD   69.17 (+3.24%)
S&P 500   3,332.94 (-1.19%)
DOW   28,948.93 (-0.93%)
QQQ   229.84 (-2.10%)
AAPL   312.22 (-2.52%)
FB   209.13 (-2.54%)
MSFT   177.87 (-3.55%)
GOOGL   1,485.10 (-2.10%)
AMZN   2,094.70 (-2.71%)
CGC   21.88 (-1.93%)
NVDA   292.62 (-5.21%)
BABA   212.34 (-2.61%)
MU   56.30 (-4.58%)
TSLA   888.25 (-1.24%)
AMD   53.13 (-7.23%)
T   38.39 (-0.60%)
ACB   1.65 (-1.79%)
F   7.91 (-1.50%)
NFLX   379.94 (-1.57%)
BAC   34.18 (-1.95%)
DIS   138.86 (-1.08%)
GILD   69.17 (+3.24%)
S&P 500   3,332.94 (-1.19%)
DOW   28,948.93 (-0.93%)
QQQ   229.84 (-2.10%)
AAPL   312.22 (-2.52%)
FB   209.13 (-2.54%)
MSFT   177.87 (-3.55%)
GOOGL   1,485.10 (-2.10%)
AMZN   2,094.70 (-2.71%)
CGC   21.88 (-1.93%)
NVDA   292.62 (-5.21%)
BABA   212.34 (-2.61%)
MU   56.30 (-4.58%)
TSLA   888.25 (-1.24%)
AMD   53.13 (-7.23%)
T   38.39 (-0.60%)
ACB   1.65 (-1.79%)
F   7.91 (-1.50%)
NFLX   379.94 (-1.57%)
BAC   34.18 (-1.95%)
DIS   138.86 (-1.08%)
GILD   69.17 (+3.24%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 SynthorxChemoCentryxAimmune TherapeuticsRa PharmaceuticalsKaruna Therapeutics
SymbolNASDAQ:THORNASDAQ:CCXINASDAQ:AIMTNASDAQ:RARXNASDAQ:KRTX
Price Information
Current Price$67.99$48.88$26.44$46.68$98.26
52 Week RangeHoldBuyBuyHoldBuy
Analyst Ratings
Consensus RecommendationHoldBuyBuyHoldBuy
Consensus Price Target$53.80$50.00$48.82$47.50$110.13
% Upside from Price Target-20.87% downside2.30% upside84.64% upside1.76% upside12.08% upside
Trade Information
Market Cap$2.20 billion$2.83 billion$1.70 billion$2.21 billion$2.25 billion
BetaN/A2.40.041.47N/A
Average Volume474,507469,8842,118,088781,013440,737
Sales & Book Value
Annual RevenueN/A$42.88 millionN/A$2.50 millionN/A
Price / SalesN/A66.17N/A880.38N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$6.72 per share$0.29 per share$5.09 per share$4.92 per shareN/A
Price / BookN/A168.53N/A9.49N/A
Profitability
Net Income$-56,610,000.00$-37,970,000.00$-210,750,000.00$-64,940,000.00N/A
EPS($6.59)($0.76)($3.67)($2.06)N/A
Trailing P/E RatioN/AN/AN/AN/A0.00
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-143.30%N/AN/AN/A
Return on Equity (ROE)-26.09%-88.76%-104.54%-37.93%N/A
Return on Assets (ROA)-24.62%-23.42%-77.54%-35.60%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.32%0.33%0.01%N/A
Current Ratio18.87%3.12%4.64%25.73%106.93%
Quick Ratio18.87%3.12%4.64%25.73%106.93%
Ownership Information
Institutional Ownership Percentage66.12%66.24%80.66%90.82%48.74%
Insider Ownership Percentage53.20%12.20%13.75%4.30%N/A
Miscellaneous
Employees39762287213
Shares Outstanding32.34 million58.05 million62.67 million47.15 million23.41 million
Next Earnings Date3/10/2020 (Estimated)3/9/2020 (Estimated)2/27/2020 (Confirmed)3/5/2020 (Estimated)2/27/2020 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel